119 related articles for article (PubMed ID: 26339387)
1. SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading.
Pityński K; Banas T; Pietrus M; Milian-Ciesielska K; Ludwin A; Okon K
Int J Clin Exp Pathol; 2015; 8(7):8189-98. PubMed ID: 26339387
[TBL] [Abstract][Full Text] [Related]
2. Expression of microRNA-145, OCT4, and SOX2 in double primary endometrioid endometrial and ovarian carcinomas.
Zhang R; Jiao J; Chu H; Yang H; Wang L; Gao N
Histol Histopathol; 2018 Aug; 33(8):859-870. PubMed ID: 29569698
[TBL] [Abstract][Full Text] [Related]
3. Association of the immunohistochemical detection of gamma-glutamyl transferase expression with clinicopathological findings in postmenopausal women with endometrioid adenocarcinoma of the uterus.
Pitynski K; Ozimek T; Galuszka N; Banas T; Milian-Ciesielska K; Pietrus M; Okon K; Mikos M; Juszczyk G; Sinczak-Kuta A; Stoj A
J Physiol Pharmacol; 2016 Jun; 67(3):395-402. PubMed ID: 27512000
[TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma.
Ji J; Wei X; Wang Y
Int J Clin Exp Pathol; 2014; 7(5):2470-6. PubMed ID: 24966958
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
[TBL] [Abstract][Full Text] [Related]
6. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
7. Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma.
Zhou X; Zhou YP; Huang GR; Gong BL; Yang B; Zhang DX; Hu P; Xu SR
Int J Gynecol Pathol; 2011 May; 30(3):262-70. PubMed ID: 21464727
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma.
Xu X; Feng L; Liu Y; Zhou WX; Ma YC; Fei GJ; An N; Li Y; Wu X; Yao F; Cheng SJ; Lu XH
World J Gastroenterol; 2014 Dec; 20(47):17883-93. PubMed ID: 25548486
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
[TBL] [Abstract][Full Text] [Related]
11. p53 protein overexpression in early stage endometrial cancer.
Kohlberger P; Gitsch G; Loesch A; Tempfer C; Kaider A; Reinthaller A; Kainz C; Breitenecker G
Gynecol Oncol; 1996 Aug; 62(2):213-7. PubMed ID: 8751552
[TBL] [Abstract][Full Text] [Related]
12. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
13. ras p21 immunohistochemical detection in human endometrial carcinomas.
Semczuk A; Miturski R; Baranowski W; Jakowicki JA
Gynecol Obstet Invest; 1997; 44(2):132-5. PubMed ID: 9286729
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
15. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
[TBL] [Abstract][Full Text] [Related]
16. Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients.
Honing J; Pavlov KV; Meijer C; Smit JK; Boersma-van Ek W; Karrenbeld A; Burgerhof JG; Kruyt FA; Plukker JT
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S657-64. PubMed ID: 24833101
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.
Wu Y; Liu S; Xin H; Jiang J; Younglai E; Sun S; Wang H
Cancer; 2011 Sep; 117(17):3989-98. PubMed ID: 21365617
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer.
Cicchillitti L; Corrado G; Carosi M; Dabrowska ME; Loria R; Falcioni R; Cutillo G; Piaggio G; Vizza E
Oncotarget; 2017 Jan; 8(5):7935-7945. PubMed ID: 27974701
[TBL] [Abstract][Full Text] [Related]
19. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.
Kim BW; Cho H; Choi CH; Ylaya K; Chung JY; Kim JH; Hewitt SM
BMC Cancer; 2015 Dec; 15():1015. PubMed ID: 26706028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
